Ying Fu

3PUBLICATIONS
2CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 31, 2022
Selenium substituted axitinib reduces axitinib side effects and maintains its anti-renal tumor activity.

Ying Fu, Rengui Saxu, Kadir Ahmad Ridwan

|May 14, 2022
Losartan Alleviates the Side Effects and Maintains the Anticancer Activity of Axitinib.

Ying Fu, Rengui Saxu, Kadir Ahmad Ridwan

|Aug 27, 2021
Anastatin Derivatives Alleviate Myocardial Ischemia-Reperfusion Injury via Antioxidative Properties.

Ying Fu, Cai Zhao, Rengui Saxu

Pageof 1

Frequent Collaborators

3 joint publications

Yuou Teng

1 joint publications

Kadir Ahmad Ridwan